The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.

Affiliation

Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop A06, Atlanta, GA, 30329-4027, USA. Electronic address: [Email]

Abstract

Malaria infection poses a significant risk in pregnancy, yet chemoprophylaxis for pregnant women is limited. A systematic review was conducted to evaluate the incidence of adverse outcomes after atovaquone-proguanil (AP) exposure during pregnancy.

Keywords

Antimalarials,Chemoprophylaxis,Female,Humans,Infant,Newborns,Plasmodium,Pregnancy,

OUR Recent Articles